Skip to main content

Animations

MJFF Publications

8361 - 8370 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2024
  • 2025
  • 2025
  • 2018
  • 2025
  • 2025
  • 2017
  • 2023
  • 2022
  • Summary Details
    OPEN
    Title: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab374
    Citation Count: 20
  • Summary Details
    RESTRICTED
    Title: A deep 1-D CNN learning approach with data augmentation for classification of Parkinson’s disease and scans without evidence of dopamine deficit (SWEDD)
    Journal Name: Biomedical Signal Processing and Control
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bspc.2024.106008
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Accurate prediction of absolute prokaryotic abundance from DNA concentration
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2025.101030
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Open-source platforms to investigate analytical flexibility in neuroimaging
    Journal Name: Imaging Neuroscience
    Publisher: MIT Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1162/imag.a.79
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.005
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Prospective longitudinal cohort of Argentinean patients with progressive supranuclear palsy and corticobasal syndrome: A platform for epidemiological and translational research
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100339
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Motor asymmetry in Parkinson’s disease: Diagnostic thresholds based on clinical scores and DaTSCAN imaging
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100350
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Predicting primary progressive aphasias with support vector machine approaches in structural MRI data
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.02.003
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease Models
    Journal Name: Antioxidants
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/antiox12030582
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.04.001
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.